<!DOCTYPE html>
<html class="client-nojs" lang="en" dir="ltr">
<head>
<meta charset="UTF-8"/>
<title>Ologen - EyeWiki</title>
<script>document.documentElement.className="client-js";RLCONF={"wgBreakFrames":!1,"wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"mdy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgRequestId":"ZAVjXAe1fdyHj2Y9gmtVHQAAAB4","wgCSPNonce":!1,"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":!1,"wgNamespaceNumber":0,"wgPageName":"Ologen","wgTitle":"Ologen","wgCurRevisionId":87686,"wgRevisionId":87686,"wgArticleId":17650,"wgIsArticle":!0,"wgIsRedirect":!1,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["Articles","Glaucoma"],"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgRelevantPageName":"Ologen","wgRelevantArticleId":17650,"wgIsProbablyEditable":!1,"wgRelevantPageIsProbablyEditable":!1,"wgRestrictionEdit":[],"wgRestrictionMove":[],"sdgDownArrowImage":"/w/extensions/SemanticDrilldown/skins/down-arrow.png"
,"sdgRightArrowImage":"/w/extensions/SemanticDrilldown/skins/right-arrow.png","wgCiteDrawerEnableDesktop":!1,"wgCiteDrawerEnableMobile":!0,"wgCiteDrawerTheme":"dark","wgPageFormsTargetName":null,"wgPageFormsAutocompleteValues":[],"wgPageFormsAutocompleteOnAllChars":!1,"wgPageFormsFieldProperties":[],"wgPageFormsCargoFields":[],"wgPageFormsDependentFields":[],"wgPageFormsCalendarValues":[],"wgPageFormsCalendarParams":[],"wgPageFormsCalendarHTML":null,"wgPageFormsGridValues":[],"wgPageFormsGridParams":[],"wgPageFormsContLangYes":null,"wgPageFormsContLangNo":null,"wgPageFormsContLangMonths":[],"wgPageFormsHeightForMinimizingInstances":800,"wgPageFormsShowOnSelect":[],"wgPageFormsScriptPath":"/w/extensions/PageForms","edgValues":[],"wgPageFormsEDSettings":null,"wgAmericanDates":!0,"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","pageVariantFallbacks":"en"},"srfFilteredConfig":null,"wgEditSubmitButtonLabelPublish":!1};RLSTATE={"site.styles":"ready","noscript":
"ready","user.styles":"ready","user":"ready","user.options":"loading","ext.cite.styles":"ready","mediawiki.ui.button":"ready","skins.chameleon":"ready","zzz.ext.bootstrap.styles":"ready","mediawiki.toc.styles":"ready","ext.CookieWarning.styles":"ready","oojs-ui-core.styles":"ready","oojs-ui.styles.indicators":"ready","mediawiki.widgets.styles":"ready","oojs-ui-core.icons":"ready","ext.visualEditor.desktopArticleTarget.noscript":"ready","ext.srf.styles":"ready","ext.smw.style":"ready","ext.smw.tooltip.styles":"ready"};RLPAGEMODULES=["ext.smw.style","ext.smw.tooltips","ext.cite.ux-enhancements","smw.entityexaminer","site","mediawiki.page.startup","mediawiki.page.ready","mediawiki.toc","ext.citedrawer.main","ext.CookieWarning","ext.visualEditor.desktopArticleTarget.init","ext.visualEditor.targetLoader","ext.eyeWiki","ext.eyeWiki.slideshow","sentry.init","ext.bootstrap.scripts"];</script>
<script>(RLQ=window.RLQ||[]).push(function(){mw.loader.implement("user.options@1hzgi",function($,jQuery,require,module){/*@nomin*/mw.user.tokens.set({"patrolToken":"+\\","watchToken":"+\\","csrfToken":"+\\"});
});});</script>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.CookieWarning.styles%7Cext.cite.styles%7Cext.visualEditor.desktopArticleTarget.noscript%7Cmediawiki.toc.styles%7Cmediawiki.ui.button%7Cmediawiki.widgets.styles%7Coojs-ui-core.icons%2Cstyles%7Coojs-ui.styles.indicators%7Cskins.chameleon%7Czzz.ext.bootstrap.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.smw.style%7Cext.smw.tooltip.styles&amp;only=styles&amp;skin=chameleon"/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=ext.srf.styles&amp;only=styles&amp;skin=chameleon"/>
<script async="" src="/w/load.php?lang=en&amp;modules=startup&amp;only=scripts&amp;raw=1&amp;skin=chameleon"></script>
<style>#mw-indicator-mw-helplink {display:none;}</style>
<meta name="ResourceLoaderDynamicStyles" content=""/>
<link rel="stylesheet" href="/w/load.php?lang=en&amp;modules=site.styles&amp;only=styles&amp;skin=chameleon"/>
<meta name="generator" content="MediaWiki 1.35.8"/>
<meta name="description" content="This article briefly introduces Ologen as a wound modulator used in glaucoma surgeries. It functions as a scaffold for the fibroblast cells during the healing process and helps maintain the new aqueous fluid pathway."/>
<meta name="date" content="2022-12-24"/>
<meta name="WT.seg_1" content="0"/>
<meta name="google-site-verification" content="mtQvMIGqpWB4oyYM5mux15MHU-3qWI0bWtyRa2b5rlk"/>
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"/>
<link rel="alternate" type="application/rdf+xml" title="Ologen" href="/w/index.php?title=Special:ExportRDF/Ologen&amp;xmlmime=rdf"/>
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico"/>
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="EyeWiki (en)"/>
<link rel="EditURI" type="application/rsd+xml" href="https://eyewiki.org/w/api.php?action=rsd"/>
<link rel="preconnect" href="https://fonts.gstatic.com">
<link href="https://fonts.googleapis.com/css2?family=Lato:ital,wght@0,400;0,700;1,400&display=swap" rel="stylesheet">
<!-- Favicons MEYE-108 -->
<link rel="apple-touch-icon" sizes="120x120" href="/w/extensions/EyeWiki/favicons/apple-touch-icon.png">
<link rel="icon" type="image/png" sizes="32x32" href="/w/extensions/EyeWiki/favicons/favicon-32x32.png">
<link rel="icon" type="image/png" sizes="16x16" href="/w/extensions/EyeWiki/favicons/favicon-16x16.png">
<link rel="manifest" href="/w/extensions/EyeWiki/favicons/site.webmanifest">
<link rel="mask-icon" href="/w/extensions/EyeWiki/favicons/safari-pinned-tab.svg" color="#603cba">
<link rel="shortcut icon" href="/w/extensions/EyeWiki/favicons/favicon.ico">
<meta name="msapplication-TileColor" content="#603cba">
<meta name="msapplication-config" content="/w/extensions/EyeWiki/favicons/browserconfig.xml">
<meta name="theme-color" content="#ffffff">
<script> window.interdeal = { "sitekey": "81c701489fb8bb4ab90ca1cb0931f9c5", "Position": "Left", "Menulang": "EN", "domains": { "js": "https://cdn.equalweb.com/", "acc": "https://access.equalweb.com/" }, "btnStyle": { "vPosition": [ "80%", null ], "scale": [ "0.8", "0.8" ], "color": { "main": "#1876c9" }, "icon": { "type": 1, "outline": false } } }; (function(doc, head, body){ var coreCall = doc.createElement('script'); coreCall.src = 'https://cdn.equalweb.com/core/4.3.8/accessibility.js'; coreCall.defer = true; coreCall.integrity = 'sha512-u6i35wNTfRZXp0KDwSb3TntaIKI2ItCt/H/KcYIsBeVbaVMerEQLBnU5/ztfBg9aSW1gg7AN4CqCu9a455jkUg=='; coreCall.crossOrigin = 'anonymous'; coreCall.setAttribute('data-cfasync', true ); body? body.appendChild(coreCall) : head.appendChild(coreCall); })(document, document.head, document.body); </script>
<!--[if lt IE 9]><script src="/w/resources/lib/html5shiv/html5shiv.js"></script><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr mw-hide-empty-elt ns-0 ns-subject page-Ologen rootpage-Ologen layout-standard skin-chameleon action-view">
	<div class="flex-fill container">
		<div class="row">
			<div class="flex-grow-0 col-12 col-cmln-6 d-flex flex-column flex-md-row w-md-100 justify-content-start align-items-center col">
					<div class="float-left mr-3 mb-2"><a href="//aao.org"><img id="aao-logo" src="/w/extensions/EyeWiki/skins/chameleon/AAO_Logo.png"></a></div>
                		
				<!-- logo and main page link -->
				<div id="p-logo" class="p-logo" role="banner">
					<a href="/Main_Page" title="Visit the main page"><img src="/w/extensions/EyeWiki/skins/chameleon/EyeWiki_Logo.png" alt="EyeWiki"/></a>
				</div>
			</div>
			<div class="ml-auto col-12 col-cmln col">
				<div class="row">
					<div class="col">
						<!-- personal tools -->
						<div class="p-personal pull-right" id="p-personal" >
							<ul class="p-personal-tools" >
								<li id="pt-createaccount"><a href="/w/index.php?title=Special:CreateAccount&amp;returnto=Ologen" title="You are encouraged to create an account and log in; however, it is not mandatory" class="pt-createaccount">Create account</a></li>
								<li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Ologen" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o" class="pt-login">Log in</a></li>
							</ul>
						</div>

					</div>
				</div>
				<div class="row">
					<div class="col">
						<!-- search form -->
						<div  id="p-search" class="p-search pull-right" role="search"  >
							<form  id="searchform" class="mw-search" action="/w/index.php" >
								<input type="hidden" name="title" value=" Special:Search" />
								<div class="input-group">
									<input name="search" placeholder="Search EyeWiki" title="Search EyeWiki [f]" accesskey="f" id="searchInput" class="form-control"/>
									<div class="input-group-append">
										<button value="Go" id="searchGoButton" name="go" type="submit" class="search-btn searchGoButton" aria-label="Go to page" title="Go to a page with this exact name if it exists"></button>
									</div>
								</div>
							</form>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar collapsible mb-3 mt-2 p-1 mt-cmln-0" role="navigation" id="mw-navigation">
					<button type="button" class="navbar-toggler" data-toggle="collapse" data-target="#hbpzyy9dz6"></button>
					<div class="collapse navbar-collapse hbpzyy9dz6" id="hbpzyy9dz6">
						<div class="navbar-nav"><div class="nav-item"><a class="nav-link fas fa-home"  href="/Main_Page">Main Page</a></div><div class="nav-item"><a class="nav-link fas fa-book"  href="/Category:Articles">Articles</a></div><div class="nav-item"><a class="nav-link fas fa-play"  href="/Help:Getting_Started">Getting Started</a></div><div class="nav-item"><a class="nav-link fas fa-question"  href="/Help:Contents">Help</a></div><div class="nav-item"><a class="nav-link fas fa-backward"  href="/Special:RecentChanges">Recent changes</a></div><div class="nav-item"><a class="nav-link fas fa-door-open"  href="#">My Portal</a></div>
						</div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- Content navigation -->
				<div class="mb-3 pagetools p-contentnavigation" id="p-contentnavigation">
					<!-- namespaces -->
					<div id="p-namespaces" class="p-namespaces">
						<div class="tab-group">
							<div id="ca-nstab-main" class="selected"><a href="/Ologen" title="View the content page [c]" accesskey="c" class="selected ca-nstab-main">Page</a></div>
							<div id="ca-talk" class="new"><a href="/w/index.php?title=Talk:Ologen&amp;action=edit&amp;redlink=1" rel="discussion" title="Discussion about the content page (page does not exist) [t]" accesskey="t" class="new ca-talk">Discussion</a></div>
						</div>
					</div>
					<!-- views -->
					<div id="p-views" class="p-views">
						<div class="tab-group">
							<div id="ca-formedit"><a href="/w/index.php?title=Ologen&amp;action=formedit" title="Edit this page with a form [&amp;]" accesskey="&amp;" class="ca-formedit">View form</a></div>
							<div id="ca-viewsource"><a href="/w/index.php?title=Ologen&amp;action=edit" title="This page is protected.&#10;You can view its source [e]" accesskey="e" class="ca-viewsource">View source</a></div>
							<div id="ca-history"><a href="/w/index.php?title=Ologen&amp;action=history" title="Past revisions of this page [h]" accesskey="h" class="ca-history">History</a></div>
						</div>
					</div>
				</div>
			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">

			</div>
		</div>
		<div class="row">
			<div class="col-auto mx-auto col">
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- start the content area -->
				<div id="content" class="mw-body content"><a id="top" class="top"></a>
					<div id="mw-indicators" class="mw-indicators">
					<div id="mw-indicator-smw-entity-examiner" class="mw-indicator mw-indicator-smw-entity-examiner"><div class="smw-entity-examiner smw-indicator-vertical-bar-loader" data-subject="Ologen#0##" data-dir="ltr" data-uselang="" title="Running an examiner in the background"></div></div>
				</div>
						<div class="contentHeader">
						<!-- title of the page -->
						<h1 id="firstHeading" class="firstHeading">Ologen</h1>
						<!-- tagline; usually goes something like "From WikiName" primary purpose of this seems to be for printing to identify the source of the content -->
						<div id="siteSub" class="siteSub">From EyeWiki</div><div id="jump-to-nav" class="mw-jump jump-to-nav">Jump to:<a href="#mw-navigation">navigation</a>, <a href="#p-search">search</a></div>
					</div>
					<div id="bodyContent" class="bodyContent">
						<!-- body text -->

						<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><div class="mw-parser-output"><div id="article-header" data-description2-ignore=""><div id="contest" style="margin-bottom: 6px;">
</div>
<div class="infobox contributors">
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header"><a href="/Property:Authors" title="Property:Authors">Article initiated by</a>:
</div>
<div class="info-section-body"><a href="/User:Raiza.Perez" title="User:Raiza.Perez">Raiza Algernon Perez lucena</a>,&#8201;<a href="/w/index.php?title=User:Ahmed.Ike&amp;action=formedit&amp;redlink=1" class="new" title="User:Ahmed.Ike (page does not exist)">Ahmed.Ike</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">All authors and contributors:
</div>
<div class="info-section-body"> <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>,&#160;<a href="/User:Shawn.Gulati" title="User:Shawn.Gulati">Shawn Gulati</a>,&#160;<a href="/w/index.php?title=User:Chunyu.Guo.&amp;action=formedit&amp;redlink=1" class="new" title="User:Chunyu.Guo. (page does not exist)">Chunyu.Guo.</a>,&#160;<a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a>,&#160;<a href="/User:Raiza.Perez" title="User:Raiza.Perez">Raiza Algernon Perez lucena</a>
</div>
</div>
<div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Assigned editor:
</div>
<div class="info-section-body"> <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a></div>
</div><div class="info-section" style="margin-bottom: 10px;">
<div class="info-section-header">Review:
</div>
<div class="info-section-body">Assigned status <b>Up to Date</b>
</div>
</div>&#160;by <a href="/User:Ahmad.A.Aref" title="User:Ahmad.A.Aref">Ahmad A. Aref, MD, MBA</a> on December 25, 2022.
</div>
<div style="display:none;">
<table cellspacing="5">

<tbody><tr>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Ologen&amp;action=formedit">add</a></small>
</td></tr>
<tr>
<th align="right"><b><a href="/Property:Contributing_Editors" title="Property:Contributing Editors">Contributing Editors</a>:</b>
</th>
<td><small><a rel="nofollow" class="external text" href="https://eyewiki.org/w/index.php?title=Ologen&amp;action=formedit">add</a></small>
</td></tr>
</tbody></table></div>
<div style="display:none;">
<p><br />
</p>
</div>
<div id="local-videos">
</div>
</div>
<div class="thumb tright"><div class="thumbinner" style="width:302px;"><a href="/File:Ologen_.png" class="image"><img alt="" src="/w/images/1/thumb/b/ba/Ologen_.png/300px-Ologen_.png" decoding="async" width="300" height="230" class="thumbimage" srcset="/w/images/1/thumb/b/ba/Ologen_.png/450px-Ologen_.png 1.5x, /w/images/1/thumb/b/ba/Ologen_.png/600px-Ologen_.png 2x" /></a>  <div class="thumbcaption"><div class="magnify"><a href="/File:Ologen_.png" class="internal" title="Enlarge"></a></div><b>(a) Biodegradable Ologen matrix (b)position of Ologen above scleral flap (c) Scanning Electron microscope image of Ologen with pores</b></div></div></div>
<div id="toc" class="toc" role="navigation" aria-labelledby="mw-toc-heading"><input type="checkbox" role="button" id="toctogglecheckbox" class="toctogglecheckbox" style="display:none" /><div class="toctitle" lang="en" dir="ltr"><h2 id="mw-toc-heading">Contents</h2><span class="toctogglespan"><label class="toctogglelabel" for="toctogglecheckbox"></label></span></div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Surgical_Therapy"><span class="tocnumber">1</span> <span class="toctext">Surgical Therapy</span></a>
<ul>
<li class="toclevel-2 tocsection-2"><a href="#Ologen"><span class="tocnumber">1.1</span> <span class="toctext">Ologen</span></a></li>
<li class="toclevel-2 tocsection-3"><a href="#Mechanism"><span class="tocnumber">1.2</span> <span class="toctext">Mechanism</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Indication"><span class="tocnumber">1.3</span> <span class="toctext">Indication</span></a></li>
<li class="toclevel-2 tocsection-5"><a href="#Contraindication"><span class="tocnumber">1.4</span> <span class="toctext">Contraindication</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-6"><a href="#Surgical_Techniques"><span class="tocnumber">2</span> <span class="toctext">Surgical Techniques</span></a></li>
<li class="toclevel-1 tocsection-7"><a href="#Outcomes"><span class="tocnumber">3</span> <span class="toctext">Outcomes</span></a>
<ul>
<li class="toclevel-2 tocsection-8"><a href="#Mitomycin-C_.28MMC.29_versus_Ologen"><span class="tocnumber">3.1</span> <span class="toctext">Mitomycin-C (MMC) versus Ologen</span></a></li>
<li class="toclevel-2 tocsection-9"><a href="#XEN_and_Ologen"><span class="tocnumber">3.2</span> <span class="toctext">XEN and Ologen</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Ex-PRESS_Mini_Glaucoma_Shunt_and_Ologen"><span class="tocnumber">3.3</span> <span class="toctext">Ex-PRESS Mini Glaucoma Shunt and Ologen</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Viscocanalostomy_and_Ologen"><span class="tocnumber">3.4</span> <span class="toctext">Viscocanalostomy and Ologen</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Conclusions"><span class="tocnumber">4</span> <span class="toctext">Conclusions</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#References"><span class="tocnumber">5</span> <span class="toctext">References</span></a></li>
</ul>
</div>

<h1><span class="mw-headline" id="Surgical_Therapy">Surgical Therapy</span></h1>
<h2><span class="mw-headline" id="Ologen">Ologen</span></h2>
<p>As a key risk factor of glaucoma, intraocular pressure (IOP) is the main target of treatment. Incisional surgeries, such as <a href="/Trabeculectomy" title="Trabeculectomy">trabeculectomy</a> and glaucoma drainage device implantation, create an alternative aqueous pathway to physiologic outflow, aiming to decrease IOP. These surgeries are indicated when medical management, or prior less invasive surgical options, provide inadequate control. 
</p><p>Invented several decades ago, trabeculectomy still functions as a gold standard for filtering surgery.<sup id="cite_ref-alSemari1_1-0" class="reference"><a href="#cite_note-alSemari1-1">&#91;1&#93;</a></sup> <sup id="cite_ref-he2_2-0" class="reference"><a href="#cite_note-he2-2">&#91;2&#93;</a></sup> The success rate for primary trabeculectomy ranges from 48% to 98% <sup id="cite_ref-bhatia3_3-0" class="reference"><a href="#cite_note-bhatia3-3">&#91;3&#93;</a></sup>, but postoperative subconjunctival tissue fibrosis may cause bleb failure, thereby reducing success rate. Ahmed Glaucoma Valve (AGV, New World Medical, Inc.) implantation is another surgical option; comparable failure and complication rates were reported at a 3-year follow-up.<sup id="cite_ref-kumari4_4-0" class="reference"><a href="#cite_note-kumari4-4">&#91;4&#93;</a></sup> Xen Gel Stent (Allergan) and Ex-press Mini Shunt devices are also used as surgical alternatives. Like trabeculectomy, all filtering surgeries share the issue of possible postoperative fibrosis, which may limit long-term outflow and IOP-lowering effect.
</p><p>With the emergence of adjunct antimetabolites like 5-fluorouracil and mitomycin C (MMC), subconjunctival scarring and its associated failure rate have decreased considerably. However, this benefit is limited by toxicity-related complications, including late-term wound leaks, hypotony, blebitis, avascular blebs, and <a href="/Endophthalmitis" title="Endophthalmitis">endophthalmitis</a>.<sup id="cite_ref-he2_2-1" class="reference"><a href="#cite_note-he2-2">&#91;2&#93;</a></sup><sup id="cite_ref-eldaly5_5-0" class="reference"><a href="#cite_note-eldaly5-5">&#91;5&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Mechanism">Mechanism</span></h2>
<p>Ologen is a porous, biodegradable, porcine collagen implant comprised of lyophilized, crosslinked type I atelocollagen (≥ 90%) and glycosaminoglycans (≤ 10%).<sup id="cite_ref-he2_2-2" class="reference"><a href="#cite_note-he2-2">&#91;2&#93;</a></sup> <sup id="cite_ref-eldaly5_5-1" class="reference"><a href="#cite_note-eldaly5-5">&#91;5&#93;</a></sup><sup id="cite_ref-gad6_6-0" class="reference"><a href="#cite_note-gad6-6">&#91;6&#93;</a></sup> The scaffold provides irregular seeding space for fibroblasts, preventing the formation of dense connective tissue. Furthermore, the Ologen implant acts as a reservoir and helps in the mechanical separation of episcleral and conjunctival surfaces, thereby limiting their adhesions.<sup id="cite_ref-gad6_6-1" class="reference"><a href="#cite_note-gad6-6">&#91;6&#93;</a></sup> The material degrades within five months, leaving loose connective tissue. <sup id="cite_ref-eldaly5_5-2" class="reference"><a href="#cite_note-eldaly5-5">&#91;5&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="Indication">Indication</span></h2>
<p>Ologen is currently indicated as an adjunct for trabeculectomy, bleb revisions, primary Xen Gel Stent implantation, Xen Gel Stent revisions, and AGV to reduce postoperative scarring. Patients with a higher risk for postoperative scarring, including those with a history of conjunctival surgery, thick tenon capsule, previous failed trabeculectomy or tube, uveitis, or <a href="/Neovascular_Glaucoma" title="Neovascular Glaucoma">neovascular glaucoma</a> may also be considered.
</p>
<h2><span class="mw-headline" id="Contraindication">Contraindication</span></h2>
<p>Ologen is not reported with any absolute contraindication, but caution may be exercised in patients with hypersensitivity to porcine collagen.
</p>
<h1><span class="mw-headline" id="Surgical_Techniques">Surgical Techniques</span></h1>
<p>Ologen may be added during any filtering procedure before the conjunctival flap is closed for both limbus and fornix-based approaches. It does not require pre-shaping or fixation. Once properly placed above the scleral flap edge, aqueous humor will absorb into the Ologen implant and tension from the conjunctival surface sutured above will help to shape the material to an optimal contour. The inflated Ologen and conjunctival sutures will both help to control aqueous flow and thereby limit hypotony. It is important to note that since the Ologen sits above the posterior edge of the scleral flap, the scleral suture sites are usually hidden, which may interfere with possible laser suture lysis. Adjustable sutures may be used as an alternative.
</p>
<h1><span class="mw-headline" id="Outcomes">Outcomes</span></h1>
<h2><span id="Mitomycin-C_(MMC)_versus_Ologen"></span><span class="mw-headline" id="Mitomycin-C_.28MMC.29_versus_Ologen">Mitomycin-C (MMC) versus Ologen</span></h2>
<p>Recent studies have shown that trabeculectomy with Ologen has a similar success rate to trabeculectomy with MMC for reducing IOP for 2 years of follow-up.<sup id="cite_ref-he2_2-3" class="reference"><a href="#cite_note-he2-2">&#91;2&#93;</a></sup><sup id="cite_ref-perez7_7-0" class="reference"><a href="#cite_note-perez7-7">&#91;7&#93;</a></sup> Perez et al. studied 58 patients managed by the same surgeon and surgical procedure to obtain consistent results. With Ologen implants, there were no significant adverse events during 36 months of follow-up. Blebs were also described as normal, with posterior diffusion in 88% of patients. Further, Ologen implantation reduced operative time and postoperative management by not requiring lysis of the scleral flap sutures. The study concluded that Ologen serves as the better agent, particularly for poor MMC candidates such as pregnant women or previous blebitis patients in the contralateral eye following usage of MMC.<sup id="cite_ref-perez7_7-1" class="reference"><a href="#cite_note-perez7-7">&#91;7&#93;</a></sup>
</p>
<h2><span class="mw-headline" id="XEN_and_Ologen">XEN and Ologen</span></h2>
<p>Navero‐Rodríguez et al. observed slightly lower IOP with Ologen implants than without Ologen in association with Xen Gel Stent implantation with a mean IOP reduction post-surgery of 24.5% with Ologen and 19.7% without Ologen.<sup id="cite_ref-naverorodr.C3.ADguez8_8-0" class="reference"><a href="#cite_note-naverorodr.C3.ADguez8-8">&#91;8&#93;</a></sup> Complications such as hypotony, implant extrusion, bleb formation, <a href="/Corneal_Edema" title="Corneal Edema">corneal edema</a>, and tenon cyst were noted in this report. However, complication rates were lower with Ologen compared to those of Xen alone.
</p><p><br />
</p>
<h2><span class="mw-headline" id="Ex-PRESS_Mini_Glaucoma_Shunt_and_Ologen">Ex-PRESS Mini Glaucoma Shunt and Ologen</span></h2>
<p>Bhatkoti et al. conducted a randomized trial comparing trabeculectomy with Express and Ologen in 33 open-angle glaucoma (OAG) patients.<sup id="cite_ref-bhatkoti9_9-0" class="reference"><a href="#cite_note-bhatkoti9-9">&#91;9&#93;</a></sup> The study categorized two groups of patients - Group A (trabeculectomy with Express) and Group B (trabeculectomy with Ologen). The baseline IOP ranged from 22 to 36 mm Hg in Group A and 23 to 36 mm Hg in Group B. The postoperative IOP success rate of both groups was 85%, with successful IOP reduction defined as 21 mm Hg or lower. The visual acuity with Express had faster recovery than with Ologen. 
</p>
<h2><span class="mw-headline" id="Viscocanalostomy_and_Ologen">Viscocanalostomy and Ologen</span></h2>
<p>Gad et al. examined the efficacy of Ologen in phaco-viscocanalostomy with OAG.<sup id="cite_ref-gad10_10-0" class="reference"><a href="#cite_note-gad10-10">&#91;10&#93;</a></sup>  Combined phacoemulsification and viscocanalostomy with Ologen implant was compared to combined phacoemulsification and viscocanalostomy without Ologen. No considerable operative or postoperative complications were observed in either group. During the follow-up of 2 years, mean IOP decreased significantly in the Ologen group and the study concluded that the Ologen group had a higher success rate. 32 eyes (80%) were deemed to have achieved successful IOP reduction in the Ologen group, and 23 eyes (59%) achieved successful IOP reduction without Ologen. 
AGV and Ologen
</p><p>Several studies have investigated the clinical advantages of Ologen in trabeculectomy, but the literature on Ologen with AGV is limited.
</p><p>Sastre-Ibáñez et al. determined the safety and efficacy of Ologen with AGV through a randomized trial of 58 patients that were followed for one year.<sup id="cite_ref-sastreib.C3.A1.C3.B1ez11_11-0" class="reference"><a href="#cite_note-sastreib.C3.A1.C3.B1ez11-11">&#91;11&#93;</a></sup> Conventional AGV surgery (without Ologen or antifibrotic usage) was done in 31 eyes, and another group of 27 eyes Ologen implants were placed over the AGV plate.  The study observed no differences in efficacy between the two groups and concluded there was no benefit of Ologen with AGV.
</p><p>Jacobson et al. investigated the impact of AGV with and without Ologen in a pediatric population between 2012 to 2020.<sup id="cite_ref-jacobson12_12-0" class="reference"><a href="#cite_note-jacobson12-12">&#91;12&#93;</a></sup> The study compared 16 eyes with standalone AGV to 6 eyes with AGV with Ologen (OAGV). The study observed a 100% success rate in the OAGV group vs. 31% in the standalone AGV group. Success was defined as an IOP of 5-20 mm Hg without medications and additional surgeries. The desired postoperative IOP was maintained during a one-year follow-up in the OAGV group. In conclusion, Ologen raised the success rate of AGV in childhood glaucoma. In addition, Ologen reduced the hypertensive period and decreased postoperative medication burden. A long follow-up with more eyes is needed for a better understanding of the effectiveness of OAGV.
</p>
<h1><span class="mw-headline" id="Conclusions">Conclusions</span></h1>
<p>The Ologen implant is an alternative to conventional antifibrotic agents used as adjuncts to conjunctival-based glaucoma filtering surgeries.  The implant has an excellent safety profile and efficacy data to date is encouraging.  
</p>
<h1><span class="mw-headline" id="References">References</span></h1>
<div class="mw-references-wrap mw-references-columns"><ol class="references">
<li id="cite_note-alSemari1-1"><span class="mw-cite-backlink"><a href="#cite_ref-alSemari1_1-0">↑</a></span> <span class="reference-text">AlSemari, M.A., et al., ExPress mini shunt device with trabeculectomy surgery in patients with uncontrolled glaucoma of Middle Eastern descent. Saudi J Ophthalmol, 2020. 34(3): p. 177-181.</span>
</li>
<li id="cite_note-he2-2"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-he2_2-0">2.0</a></sup> <sup><a href="#cite_ref-he2_2-1">2.1</a></sup> <sup><a href="#cite_ref-he2_2-2">2.2</a></sup> <sup><a href="#cite_ref-he2_2-3">2.3</a></sup></span> <span class="reference-text">He, M., et al., Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis. PLoS One, 2014. 9(1): p. e85782.</span>
</li>
<li id="cite_note-bhatia3-3"><span class="mw-cite-backlink"><a href="#cite_ref-bhatia3_3-0">↑</a></span> <span class="reference-text">Bhatia, J., Outcome of trabeculectomy surgery in primary open angle glaucoma. Oman Med J, 2008. 23(2): p. 86-9.</span>
</li>
<li id="cite_note-kumari4-4"><span class="mw-cite-backlink"><a href="#cite_ref-kumari4_4-0">↑</a></span> <span class="reference-text">Kumari, P. and S. Dubey, Letter to the Editor: Tube Shunt Revision With Excision of Fibrotic Capsule Using Mitomycin C With and Without Ologen-A Collagen Matrix Implant: A 3-Year Follow-up Study. J Glaucoma, 2021. 30(3): p. e126.</span>
</li>
<li id="cite_note-eldaly5-5"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-eldaly5_5-0">5.0</a></sup> <sup><a href="#cite_ref-eldaly5_5-1">5.1</a></sup> <sup><a href="#cite_ref-eldaly5_5-2">5.2</a></sup></span> <span class="reference-text">Eldaly, Z.H., et al., Comparison between Ologen implant and different concentrations of Mitomycin C as an adjuvant to trabeculectomy surgery. Oman J Ophthalmol, 2017. 10(3): p. 184-192.</span>
</li>
<li id="cite_note-gad6-6"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-gad6_6-0">6.0</a></sup> <sup><a href="#cite_ref-gad6_6-1">6.1</a></sup></span> <span class="reference-text">Gad, A.A.M., et al., Combined phacoemulsification and viscocanalostomy with Ologen implant versus combined phacoemulsification and viscocanalostomy. BMC Ophthalmol, 2019. 19(1): p. 45.</span>
</li>
<li id="cite_note-perez7-7"><span class="mw-cite-backlink">↑ <sup><a href="#cite_ref-perez7_7-0">7.0</a></sup> <sup><a href="#cite_ref-perez7_7-1">7.1</a></sup></span> <span class="reference-text">Perez, C.I., et al., Trabeculectomy combined with collagen matrix implant (Ologen). Journal of glaucoma, 2017. 26(1): p. 54-58.</span>
</li>
<li id="cite_note-naverorodr.C3.ADguez8-8"><span class="mw-cite-backlink"><a href="#cite_ref-naverorodr.C3.ADguez8_8-0">↑</a></span> <span class="reference-text">Navero‐Rodríguez, J.M., et al., Efficacy of the Ologen collagen matrix in combination with the XEN gel stent implantation in the treatment of open‐angle glaucoma: A case‐control study. Clinical &amp; Experimental Ophthalmology, 2020. 48(7): p. 1003-1005.</span>
</li>
<li id="cite_note-bhatkoti9-9"><span class="mw-cite-backlink"><a href="#cite_ref-bhatkoti9_9-0">↑</a></span> <span class="reference-text">Bhatkoti, B., et al., Trabeculectomy with Ologen implant versus trabeculectomy with P 50 Ex-PRESS shunt in <a href="/Primary_Open-Angle_Glaucoma" title="Primary Open-Angle Glaucoma">primary open-angle glaucoma</a>. Medical Journal Armed Forces India, 2021.</span>
</li>
<li id="cite_note-gad10-10"><span class="mw-cite-backlink"><a href="#cite_ref-gad10_10-0">↑</a></span> <span class="reference-text">Gad, A.A., et al., Combined phacoemulsification and viscocanalostomy with Ologen implant versus combined phacoemulsification and viscocanalostomy. BMC ophthalmology, 2019. 19(1): p. 1-7.</span>
</li>
<li id="cite_note-sastreib.C3.A1.C3.B1ez11-11"><span class="mw-cite-backlink"><a href="#cite_ref-sastreib.C3.A1.C3.B1ez11_11-0">↑</a></span> <span class="reference-text">Sastre-Ibáñez, M., et al., Efficacy of ologen matrix implant in ahmed glaucoma valve implantation. Scientific reports, 2019. 9(1): p. 1-7.</span>
</li>
<li id="cite_note-jacobson12-12"><span class="mw-cite-backlink"><a href="#cite_ref-jacobson12_12-0">↑</a></span> <span class="reference-text">Jacobson, A., C. Rojas, and B.L. Bohnsack, Ologen augmentation of Ahmed glaucoma drainage devices in pediatric glaucomas. BMC ophthalmology, 2021. 21(1): p. 1-9.</span>
</li>
</ol></div>
<!-- 
NewPP limit report
Cached time: 20230306035158
Cache expiry: 86400
Dynamic content: false
Complications: [my_variables_no_cache]
[SMW] In‐text annotation parser time: 0.001 seconds
CPU time usage: 0.152 seconds
Real time usage: 1.188 seconds
Preprocessor visited node count: 604/1000000
Post‐expand include size: 5212/2097152 bytes
Template argument size: 1893/2097152 bytes
Highest expansion depth: 11/40
Expensive parser function count: 0/100
Unstrip recursion depth: 0/20
Unstrip post‐expand size: 6380/5000000 bytes
-->
<!--
Transclusion expansion time report (%,ms,calls,template)
100.00%  757.349      1 Template:Article
100.00%  757.349      1 -total
 76.07%  576.111      4 Template:Infobox_section
 26.55%  201.052      7 Template:UserLookup
  8.16%   61.769      1 Template:Infobox_end
  2.82%   21.393      1 Template:Review_expired
  1.54%   11.674      1 Template:Get_active_contest
  0.93%    7.043      1 Template:Infobox_begin
-->
</div></div><div class="printfooter">
Retrieved from "<a dir="ltr" href="https://eyewiki.org/w/index.php?title=Ologen&amp;oldid=87686">https://eyewiki.org/w/index.php?title=Ologen&amp;oldid=87686</a>"</div>

						<!-- end body text -->
						<!-- data blocks which should go somewhere after the body text, but not before the catlinks block-->
						<div id='mw-data-after-content'>
	<div class="mw-cookiewarning-container"><div class="mw-cookiewarning-text"><span>The Academy uses cookies to analyze performance and provide relevant personalized content to users of our website.</span></div><form method="POST"><div class='oo-ui-layout oo-ui-horizontalLayout'><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-progressive oo-ui-buttonWidget'><a role='button' tabindex='0' aria-disabled='false' href='https://www.aao.org/privacy-policy' rel='nofollow' class='oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-progressive'></span><span class='oo-ui-labelElement-label'>Learn more</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-progressive'></span></a></span><span aria-disabled='false' class='oo-ui-widget oo-ui-widget-enabled oo-ui-inputWidget oo-ui-buttonElement oo-ui-buttonElement-framed oo-ui-labelElement oo-ui-flaggedElement-primary oo-ui-flaggedElement-progressive oo-ui-buttonInputWidget'><button type='submit' tabindex='0' aria-disabled='false' name='disablecookiewarning' value='OK' class='oo-ui-inputWidget-input oo-ui-buttonElement-button'><span class='oo-ui-iconElement-icon oo-ui-iconElement-noIcon oo-ui-image-invert'></span><span class='oo-ui-labelElement-label'>Accept</span><span class='oo-ui-indicatorElement-indicator oo-ui-indicatorElement-noIndicator oo-ui-image-invert'></span></button></span></div></form></div>
</div>

					</div>
					<!-- category links -->
					<div id="catlinks" class="catlinks" data-mw="interface"><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/Special:Categories" title="Special:Categories">Categories</a>: <ul><li><a href="/Category:Articles" title="Category:Articles">Articles</a></li><li><a href="/Category:Glaucoma" title="Category:Glaucoma">Glaucoma</a></li></ul></div></div>
				</div>
			</div>
		</div>
	</div>
	<div class="mb-2 mt-4 footer container">
		<div class="row">
			<div class="col">
				<!-- navigation bar -->
				<nav class="p-navbar not-collapsible small mb-2" role="navigation" id="mw-navigation-hbpzyy9fj6">
					<div class="navbar-nav">
					<!-- toolbox -->
					<div id="t-whatlinkshere" class="nav-item"><a href="/Special:WhatLinksHere/Ologen" title="A list of all wiki pages that link here [j]" accesskey="j" class="nav-link t-whatlinkshere">What links here</a></div>
					<div id="t-recentchangeslinked" class="nav-item"><a href="/Special:RecentChangesLinked/Ologen" rel="nofollow" title="Recent changes in pages linked from this page [k]" accesskey="k" class="nav-link t-recentchangeslinked">Related changes</a></div>
					<div id="t-specialpages" class="nav-item"><a href="/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q" class="nav-link t-specialpages">Special pages</a></div>
					<div id="t-print" class="nav-item"><a href="javascript:print();" rel="alternate" title="Printable version of this page [p]" accesskey="p" class="nav-link t-print">Printable version</a></div>
					<div id="t-permalink" class="nav-item"><a href="/w/index.php?title=Ologen&amp;oldid=87686" title="Permanent link to this revision of the page" class="nav-link t-permalink">Permanent link</a></div>
					<div id="t-info" class="nav-item"><a href="/w/index.php?title=Ologen&amp;action=info" title="More information about this page" class="nav-link t-info">Page information</a></div>
					</div>
				</nav>
			</div>
		</div>
		<div class="row">
			<div class="col">
				<!-- footer links -->
				<div id="footer-info" class="footer-info">
					<!-- info -->
					<div> This page was last edited on December 25, 2022, at 16:52.</div>
					<div>This page has been accessed 3,307 times.</div>
				</div>
				<!-- places -->
				<div id="footer-places" class="footer-places">
					<div><a href="/EyeWiki:Privacy_policy" title="EyeWiki:Privacy policy">Privacy policy</a></div>
					<div><a href="/EyeWiki:About" title="EyeWiki:About">About EyeWiki</a></div>
					<div><a href="/EyeWiki:General_disclaimer" title="EyeWiki:General disclaimer">Disclaimers</a></div>
				</div>
			</div>
			<div class="col">
				<!-- footer icons -->
				<div id="footer-icons" class="justify-content-end footer-icons">
					<!-- poweredby -->
					<div><a href="https://www.mediawiki.org/"><img src="/w/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="/w/resources/assets/poweredby_mediawiki_132x47.png 1.5x, /w/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" loading="lazy"/></a></div>
					<div><a href="https://www.semantic-mediawiki.org/wiki/Semantic_MediaWiki"><img src="data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAFgAAAAfCAMAAABUFvrSAAACJVBMVEXe3t62trbLy8vGxsbAwMDX19e6urqsrKxHcEzQ0NC2tratra2oqKixsbHd3eDFxcXe3t7U1NTa2trX19fQ0NDV1dWNjY2dnZ2UlJSUlJTS0tKUlJSWlpbR0dGenp79/f38/Pz+/v7t7e3v7+/u7u7s7Oz19fX29vb6+vr7+/vz8/Pz8/P4+fnw8PD39/gWTq/09PX6+vktX7b/sg8XT7F6mc/f5OwhVrNvkMthhsfT2+j7rQ/M1eZqjcmFotPs7e9Cb722xuFResK/zOObstnu7/Grvd3M1+mNqNY6aLoaUbEaUbZWfsTk6fE2Zrnp7O8bTq0kWLQuYcpcg8Xh5/Byk83a4eukud1/nM+6yeQkWcGwwuDxnRQyYrigttvI0+gpW7XGyttLdsBni8geVLo0Z9XlkCPb4u+QqtcfVLLo7PNHcr73phFGX6HsmBnpkxg6bNwnXcbX3er19vnr7/SVrdhuhLl+j70vVqY6Xqv0oxJVcbQhV76DjKTz9ffQ2evE0OZAbbzu7/PS1uFufrDnrGgpSZjy8/SQnMFddrKuekXSiCsgTKRaaZHejy9yang3VptNaqspWbnmliy3j2/m6OzT3e7x8fL4+v3p6uwaN2re0cifqLiLiZWYhYGYb0xXYn+5g0xwiMKYpc2BcHZmW2srRXpGWIhecKfilz4+WID2+PyosMywqbGqss1aVnLZq33p1sGklZqrp7dkfr7CpY9yg59Ud6QZAAAAH3RSTlPfBN/f39/f2wDf39vV3/7N2rrEz5D5c8ONuHaPuXXDImoxqwAABO1JREFUSMe1kQdz01gQgBXaBS4w9OtHwMFSdPKTUNxkW+61xN2Je4tLHJNOGukkAUINJTzaUIbO9fr7TpLtS44DZiC5b6Sn3dW+TysJaWz4cv9eZFPZu/+bhkakYR88WqP59u3vjxzdDCT7GpCD4qNH3sEGzOhB5MCR/4PmA8j25uZ33t0A23lxff5hZTIzOrz2Ph8qK936l7i1tT7hk8DAoHNsbeLWKjPdQcZ+qvX9tHMNXca1XBDXHtL6x2Bh0HWtuXUo8oTgC1gVpcdsdpew92PUYtjwzFq+E9mJYfXxx1x5l2/l5Vhy0DW6TuyQCZcR2hnswXJM0h+203471u5WKMIE5mDpspIIO8sZTMZiIbczY6+JCaI+/sJZ38qjP28+nQjkx/mcqGJ26rW3iKg/fYphCL1jNk5WbqXI0nBnu00RJ2j9bNRp6MmFS0SYIXLuUlQ5w22qizHr5MTyy2u/3XxVvHHlwtWVa/xTCQIIlEaMzrgswzA5P9BrAciYASqNoiNdjL8b0GYAHN3AGAEgzPSQc9UtYCeyBQAMO2G9PhhzXfp9qdifSCT6Lj788QQnrvWEuNPI2um0LW0D+m4A6E4AnIZOeq7ksQuJvi6eUXRW+8EWXsxNPhkYGJiSXr7Rd1qtVp9MXHkgIurzAkdFxjrj7cmKbN4K5v8RGxT2sJMTpwBflNHhUJgBdoUylzy3TuwIDBRi0hf9p9VtbW3qk30X7q2Je1IybZq7mLVWFKTSADXPoqi9AzVorda0kKTS6KkRbSgaR1GT1h5CObYiW1GU27yc5z6F9Fn/yTYedeLi9AIA6AbgxGIxAMPZcZeUHH9cFavVfY97FaNA/DbazRZVV89/61at2BTlg1JXiFtrYoBmRyd7p6/UP0XxaSDmy4pt0jmuh8qx6wQ2MmRz18TaJCUWO9xisUVhMMsoZZDiGHLLuXUbso2iatP/1HvhYu3n3bh6Pe/LUjZSj1NUJ8lSlNwahRRlMRjmyFDICikVn8+SacomdbZTVj+0mQSxweS1WqpiHK/Ncubs858f9idOJ/qKS1cv+RbFuIbMmHEvTbO4QeF25CxyD62nSbmJ1MUzRrpiwR0RPBJMpnCGxWVGXBn8TkarNGQHjuPrxOeWY4GY9FmxWHy19Gvv+ayYF6f8oYi7i8U93bjFkYokvbhWEFu8Og2ZxrUe3NMpc3vLhqqYpVV4XbwDQkpgoVwYKOR9N5d+eXB5vJevQA0pD7oVqi4WOj16vX6EYSA08WKvyeOZJw1cQ6rsnXOa/RYoM0Kls0zLuVoHhHAHL8YFXkwVCoE8uXhvMVCY8mW5Ci8eKkcgJ9azOl0UajNDFiUpj5JeloEqTgwd/iCUJP0sFMSejkpO96b4zl1fPuYiyd6Vs4GBmHSsJoYmLy/WeBTlis5rlJYrgjhe1s+XOXGEtHJOMl4VB2EHLauKdyG7JBLIc//uslRKkhOrcGJqyiU9z5UkOpVOwiGXSyQizRAfqlRc7Y5KJFnV6FReiWSV7xAWeQd/SOSq6qY18eVHq4vjlyazEJ73ScmJPVxJVKdF9MFwYpFIEL+ehvDOcSH8YXRsAa4XfwS7kd0tLfw7Sp7fl7xJywbYjTTVotfTb+849lEcb0K+2lMN/5o+tons+Rxp+PrQ8U3n0BcNSGPj4W+bPuX5ZLNo+uxwY+PfoLJHX1KXgyMAAAAASUVORK5CYII=" alt="Powered by Semantic MediaWiki" class="smw-footer" width="88" height="31" loading="lazy"/></a></div>
				</div>
			</div>
		</div>
	</div>
<script src="https://www.googletagmanager.com/gtag/js?id=UA-64665049-1" async=""></script><script>
window.dataLayer = window.dataLayer || [];
function gtag(){dataLayer.push(arguments);}
gtag('js', new Date());
gtag('config', 'UA-64665049-1', {});
</script>

<script>(RLQ=window.RLQ||[]).push(function(){mw.config.set({"wgPageParseReport":{"smw":{"limitreport-intext-parsertime":0.001},"limitreport":{"cputime":"0.152","walltime":"1.188","ppvisitednodes":{"value":604,"limit":1000000},"postexpandincludesize":{"value":5212,"limit":2097152},"templateargumentsize":{"value":1893,"limit":2097152},"expansiondepth":{"value":11,"limit":40},"expensivefunctioncount":{"value":0,"limit":100},"unstrip-depth":{"value":0,"limit":20},"unstrip-size":{"value":6380,"limit":5000000},"timingprofile":["100.00%  757.349      1 Template:Article","100.00%  757.349      1 -total"," 76.07%  576.111      4 Template:Infobox_section"," 26.55%  201.052      7 Template:UserLookup","  8.16%   61.769      1 Template:Infobox_end","  2.82%   21.393      1 Template:Review_expired","  1.54%   11.674      1 Template:Get_active_contest","  0.93%    7.043      1 Template:Infobox_begin"]},"cachereport":{"timestamp":"20230306035158","ttl":86400,"transientcontent":false}}});mw.config.set({"wgBackendResponseTime":3076});});</script></body>
</html>